Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial Sep 7, 2021
Part #1 & 2: COO Damon Michaels On Mydecine’s Collaboration With Johns Hopkins University Aug 27, 2021
Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School… Aug 18, 2021
